Loading...
XNYS
WST
Market cap20bUSD
Dec 04, Last price  
281.77USD
1D
-0.89%
1Q
12.38%
Jan 2017
232.16%
Name

West Pharmaceutical Services Inc

Chart & Performance

D1W1MN
XNYS:WST chart
P/E
41.14
P/S
7.01
EPS
6.85
Div Yield, %
0.21%
Shrs. gr., 5y
-0.46%
Rev. gr., 5y
9.47%
Revenues
2.89b
-1.94%
699,700,000913,300,0001,020,100,0001,051,100,0001,055,700,0001,104,700,0001,192,300,0001,266,400,0001,368,400,0001,421,400,0001,399,800,0001,509,100,0001,599,100,0001,717,400,0001,839,900,0002,146,900,0002,831,600,0002,886,900,0002,949,800,0002,892,700,000
Net income
493m
-16.97%
45,600,00067,100,00070,700,00086,000,00072,600,00065,300,00075,500,00080,700,000112,300,000127,100,00095,600,000143,600,000150,700,000206,900,000241,700,000346,200,000661,800,000585,900,000593,400,000492,700,000
CFO
653m
-15.85%
85,600,000143,800,000129,200,000135,000,000137,700,000138,300,000130,700,000187,400,000220,500,000182,900,000212,400,000219,400,000263,300,000288,600,000367,200,000472,500,000584,000,000724,000,000776,500,000653,400,000
Dividend
Nov 12, 20250.22 USD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components. It also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices, as well as a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. It serves pharmaceutical, diagnostic, and medical device companies. The company distributes its products through its sales force and distribution network, as well as contract sales agents and regional distributors. West Pharmaceutical Services, Inc. was incorporated in 1923 and is headquartered in Exton, Pennsylvania.
IPO date
Jul 27, 1923
Employees
10,700
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT